Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1973
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 1
1985 1
1988 1
1989 2
1991 4
1992 1
1993 3
1994 2
1995 1
1996 3
1998 1
2000 2
2001 5
2002 2
2003 1
2004 3
2005 4
2006 1
2007 1
2008 1
2009 1
2010 1
2011 3
2012 1
2013 1
2014 4
2015 6
2016 5
2017 3
2018 5
2019 14
2020 14
2021 7
2022 9
2023 10
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Hypertrophic Cardiomyopathy.
Dungu JN, Hardy-Wallace A, Dimarco AD, Savage HO. Dungu JN, et al. Curr Heart Fail Rep. 2024 Aug;21(4):428-438. doi: 10.1007/s11897-024-00654-0. Epub 2024 Mar 15. Curr Heart Fail Rep. 2024. PMID: 38488965 Review.
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition with potential for severe complications including sudden cardiac death. ...
PURPOSE OF REVIEW: Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac condition with potential for severe complic …
Cardiomyopathies in children: An overview.
Tsatsopoulou A, Protonotarios I, Xylouri Z, Papagiannis I, Anastasakis A, Germanakis I, Patrianakos A, Nyktari E, Gavras C, Papadopoulos G, Meditskou S, Lazarou E, Miliou A, Lazaros G. Tsatsopoulou A, et al. Hellenic J Cardiol. 2023 Jul-Aug;72:43-56. doi: 10.1016/j.hjc.2023.02.007. Epub 2023 Mar 3. Hellenic J Cardiol. 2023. PMID: 36870438 Free article. Review.
The annual incidence of 1 per 100,000 children appears higher during the first two years of life. Dilated and hypertrophic cardiomyopathy phenotypes share an incidence of 60% and 25%, respectively. Arrhythmogenic right ventricular cardiomyopathy (ARVC), restr …
The annual incidence of 1 per 100,000 children appears higher during the first two years of life. Dilated and hypertrophic cardiom
A systematic review and meta-analysis of the efficacy and safety of Mavacamten therapy in international cohort of 524 patients with hypertrophic cardiomyopathy.
Yacoub MS, El-Nakhal T, Hasabo EA, Shehata N, Wilson K, Ismail KH, Bakr MS, Mohsen M, Mohamed A, Abdelazim E, Ali HT, Soliman Z, Sayed A, Abdelsayed K, Caliskan K, Soliman O. Yacoub MS, et al. Heart Fail Rev. 2024 Mar;29(2):479-496. doi: 10.1007/s10741-023-10375-6. Epub 2023 Dec 19. Heart Fail Rev. 2024. PMID: 38112937 Review.
Hypertrophic cardiomyopathy (HCM) is the most common heritable myocardial disorder worldwide. ...Mavacamten also showed a significant reduction in SRT rates (RR = 0.29, 95% CI [0.21, 0.40], p < 0.00001), KCCQ clinical summary scores (MD = 8.08, 95% CI [4.8
Hypertrophic cardiomyopathy (HCM) is the most common heritable myocardial disorder worldwide. ...Mavacamten also showed a sign
The Efficacy of Cardiac Myosin Inhibitors Versus Placebo in Patients With Symptomatic Hypertrophic Cardiomyopathy: A Meta-Analysis and Systematic Review.
Yassen M, Changal K, Busken J, Royfman R, Schodowski E, Venkataramany B, Khouri SJ, Moukarbel GV. Yassen M, et al. Am J Cardiol. 2024 Jan 1;210:219-224. doi: 10.1016/j.amjcard.2023.10.059. Epub 2023 Oct 25. Am J Cardiol. 2024. PMID: 37884110
We aimed to assess the overall clinical impact of cardiac myosin inhibitors in hypertrophic cardiomyopathy (HCM). We performed a meta-analysis of published trials assessing the effect of cardiac myosin inhibitors (mavacamten and aficamten) on resting and Valsalva le …
We aimed to assess the overall clinical impact of cardiac myosin inhibitors in hypertrophic cardiomyopathy (HCM). We performed …
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies.
Aimo A, Merlo M, Porcari A, Georgiopoulos G, Pagura L, Vergaro G, Sinagra G, Emdin M, Rapezzi C. Aimo A, et al. Eur J Heart Fail. 2022 Dec;24(12):2342-2351. doi: 10.1002/ejhf.2532. Epub 2022 May 16. Eur J Heart Fail. 2022. PMID: 35509173 Free PMC article.
The prevalence of CA in different settings was as follows: bone scintigraphy for non-cardiac reasons (n = 5 studies), 1% (95% confidence interval [CI] 0%-1%); heart failure with preserved ejection fraction (n = 6), 12% (95% CI 6%-20%); heart failure with reduced or mildly reduced …
The prevalence of CA in different settings was as follows: bone scintigraphy for non-cardiac reasons (n = 5 studies), 1% (95% confidence int …
Impact of GLA Variant Classification on the Estimated Prevalence of Fabry Disease: A Systematic Review and Meta-Analysis of Screening Studies.
Monda E, Diana G, Graziani F, Rubino M, Bakalakos A, Linhart A, Germain DP, Scarpa M, Biagini E, Pieroni M, Elliott PM, Limongelli G. Monda E, et al. Circ Genom Precis Med. 2023 Dec;16(6):e004252. doi: 10.1161/CIRCGEN.123.004252. Epub 2023 Dec 4. Circ Genom Precis Med. 2023. PMID: 38047356
METHODS: We searched the EMBASE and PubMed databases on February 21, 2023. Observational studies evaluating the prevalence of FD and reporting the identified GLA variants were included. ...Using the American College of Medical Genetics and Genomics criteria, the pooled pre …
METHODS: We searched the EMBASE and PubMed databases on February 21, 2023. Observational studies evaluating the prevalence of FD and …
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis.
Mascia G, Crotti L, Groppelli A, Canepa M, Merlo AC, Benenati S, Di Donna P, Della Bona R, Soranna D, Zambon A, Porto I, Olivotto I, Parati G, Brignole M, Cecchi F. Mascia G, et al. Int J Cardiol. 2022 Jun 15;357:88-94. doi: 10.1016/j.ijcard.2022.03.028. Epub 2022 Mar 15. Int J Cardiol. 2022. PMID: 35304190 Review.
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the relevance of syncope as risk factor for sudden cardiac death and life-threatening arrhythmic events. ...Literature search of PubMed including …
AIMS: To describe the proportion of patients with syncope among those affected by hypertrophic cardiomyopathy (HCM) and the re …
Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis.
Yokoyama Y, Shimoda T, Shimada YJ, Shimamura J, Akita K, Yasuda R, Takayama H, Kuno T. Yokoyama Y, et al. Eur J Cardiothorac Surg. 2023 Mar 1;63(3):ezad043. doi: 10.1093/ejcts/ezad043. Eur J Cardiothorac Surg. 2023. PMID: 36782361
OBJECTIVES: To elucidate the optimal septal reduction therapy for obstructive hypertrophic cardiomyopathy, we conducted a meta-analysis comparing alcohol septal ablation (ASA) and septal myectomy. METHODS: MEDLINE, EMBASE and Cochrane CENTRAL were searched to identi …
OBJECTIVES: To elucidate the optimal septal reduction therapy for obstructive hypertrophic cardiomyopathy, we conducted a meta …
A systematic review of microRNAs in patients with hypertrophic cardiomyopathy.
Scolari FL, Faganello LS, Garbin HI, Piva E Mattos B, Biolo A. Scolari FL, et al. Int J Cardiol. 2021 Mar 15;327:146-154. doi: 10.1016/j.ijcard.2020.11.004. Epub 2020 Nov 16. Int J Cardiol. 2021. PMID: 33212095
BACKGROUND: Several microRNAs (miRNA) have been associated with hypertrophic cardiomyopathy (HCM), but studies differ regarding methods employed. In an attempt to understand their role in the disease, we performed a systematic review of studies assessing miRNAs and …
BACKGROUND: Several microRNAs (miRNA) have been associated with hypertrophic cardiomyopathy (HCM), but studies differ regardin …
Evaluation of Hypertrophic Cardiomyopathy: Newer Echo and MRI Approaches.
Habib M, Hoss S, Rakowski H. Habib M, et al. Curr Cardiol Rep. 2019 Jun 26;21(8):75. doi: 10.1007/s11886-019-1173-1. Curr Cardiol Rep. 2019. PMID: 31243594 Review.
PURPOSE OF REVIEW: This review discusses the basic and evolving echocardiographic and cardiac magnetic resonance (CMR) approaches in the diagnosis and management of patients with hypertrophic cardiomyopathy (HCM). RECENT FINDINGS: Newer imaging technologies and tech …
PURPOSE OF REVIEW: This review discusses the basic and evolving echocardiographic and cardiac magnetic resonance (CMR) approaches in the dia …
121 results